abstract |
The present invention provides a method of modulating cell viability, and further, a method of modulating an immune response. A composition which upregulates expression of MYC gene and / or activity of Myc polypeptide, the composition comprising (a) a fusion peptide, wherein the fusion peptide comprises (i) a transporter peptide (I) the MYC sequence; and optionally (i) the transporter peptide sequence and one or more molecules that bind the MYC sequence; said composition further comprising (b) a pharmaceutically acceptable excipient A composition comprising: The composition further comprises an antigenic moiety, wherein the antigenic moiety is a pathogen, toxoid, peptide, nucleic acid sequence, polysaccharide, or a combination thereof. [Selected figure] None |